Burden of respiratory syncytial virus in hospitalized infants and young children in Amman, Jordan

Scand J Infect Dis. 2010 May;42(5):368-74. doi: 10.3109/00365540903496544.

Abstract

Acute respiratory infections (ARI) play a major role in hospitalizations in the Middle East, but the specific viral causes are unknown. We conducted prospective viral surveillance in children <5 y of age admitted with ARI and/or fever at 2 dissimilar hospitals in Amman, Jordan during peak respiratory syncytial virus (RSV) season. We collected prospective clinical and demographic data and obtained nose/throat swabs for testing for RSV by real-time polymerase chain reaction (RT-PCR). We obtained clinical and laboratory data for 728/743 (98%) subjects enrolled. The children's median age was 4.3 months, 58.4% were males, 87% were breastfed, 4% attended day care, 67% were exposed to smokers, 7% were admitted to the intensive care unit, and 0.7% died (n = 5). Out of 728 subjects, 467 (64%) tested positive by RT-PCR for RSV. Comparing RSV-positive with RSV-negative subjects, the RSV-positive subjects had lower median age (3.6 vs 6.4 months, p < 0.001) and fewer males (55% vs 64%, p = 0.02). RSV-positive children had higher rates of oxygen use (72% vs 42%, p < 0.001), a longer hospital stay (5 vs 4 days, p = 0.001), and higher hospital charges (US$538 vs US$431, p < 0.001) than RSV-negative children. In young hospitalized Jordanian infants, the medical and financial burden of RSV was found to be high. Effective preventive measures, such as an RSV vaccine, would have a significant beneficial impact.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Cost of Illness
  • Female
  • Hospitalization / economics
  • Humans
  • Infant
  • Jordan / epidemiology
  • Length of Stay / statistics & numerical data
  • Male
  • Middle East
  • Nose / virology
  • Pharynx / virology
  • Prevalence
  • Prospective Studies
  • RNA, Viral / isolation & purification
  • Respiratory Syncytial Virus Infections / economics
  • Respiratory Syncytial Virus Infections / epidemiology*
  • Respiratory Syncytial Virus Infections / pathology
  • Respiratory Syncytial Virus, Human / isolation & purification*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sex Factors
  • United States

Substances

  • RNA, Viral